David Hallal Insider Profile

4 Followers
David Hallal, CEO, Director at Alexion Pharmaceuticals, holds 304.10K shares in Scholar Rock Holding (Ticker: SRRK), holds 355.13K shares in Seer (Ticker: SEER), holds 19.68M shares in AlloVir (Ticker: ALVR).
tipranks
David Hallal

David Hallal
Alexion Pharmaceuticals (ALXN)
CEO, Director

Ranked #4,050 out of 99,218 Corporate Insiders

Profitable Transactions

80%
16 out of 20 Profitable Transactions

Average Return

+19.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$29M
67.37%
30.14%
2.50%
0.00%
A breakdown of David Hallal's holdings

Insider Roles

AlloVir
(ALVR)
Director, Ten Percent Owner
Scholar Rock Holding
(SRRK)
Director
Seer
(SEER)
Director
iTeos Therapeutics
(ITOS)
Director
Roles that David Hallal holds in companies

Most Profitable Insider Trade

Stock:
AlloVir
(ALVR)
Rating:Informative Sell
Date:Oct 21, 2022 - Oct 21, 2023
Return:+82.20%
The most profitable trade made by David Hallal

David Hallal's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ALXN
Alexion Pharmaceuticals
Aug 10, 2016
Informative Sell
45.53K
$31.58M
Scholar Rock Holding
Jul 01, 2024
Director
Uninformative Buy
$8.71M
iTeos Therapeutics
Jun 10, 2022
Director
Informative Sell
597.21K
$0.00
AlloVir
Jun 07, 2024
Director, Ten Percent Owner
Uninformative Buy
$19.46M
Seer
Jun 14, 2024
Director
Uninformative Buy
$720.91K
List of latest transactions for each holding click on a transaction to see David Hallal's performance on stock

David Hallal insider profile FAQ

What is the percentage of profitable transactions made by David Hallal?
The percentage of profitable transactions made by David Hallal is 80%.
    What is the average return per transaction made by David Hallal?
    The average return per transaction made by David Hallal is 19.60%.
      What stocks does David Hallal hold?
      David Hallal holds: ALXN, SRRK, ITOS, ALVR, SEER stocks.
        What was David Hallal’s latest transaction?
        David Hallal latest transaction was an Uninformative Buy of ―.
          What was David Hallal's most profitable transaction?
          David Hallal’s most profitable transaction was an Informative Sell of ALVR stock on October 21, 2022. The return on the trade was 82.20%.
            What is David Hallal's role in Alexion Pharmaceuticals?
            David Hallal's role in Alexion Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.